MEDITECH launches new EHR platform to empower healthcare organisations
Electronic healthcare record (EHR) provider MEDITECH has recently launched its new platform MEDITECH Expanse, which will see the company extend its reach and connect patient care across the continuum.
Established to improve healthcare processes for over 40 years, MEDITECH drives key healthcare IT solutions across a number of platforms. Facilitating over 300bn data transactions per annum, the company works with medical professionals to increase productivity, and find new ways to support the industry through the use of innovative digital tools.
MEDITECH Expanse navigates healthcare's wide-open, virtual landscape, and analyses every area of a patient’s journey. This is enabled through breaking down previous silos within healthcare IT infrastructures, and provides an open, intuitive workspace which prioritises user satisfaction and productivity. With less time spent on their EHRs, physicians can therefore look forward to having more time and energy to focus on patients.
"Our clinicians deserve an open, dynamic workspace that allows them to connect care the way that works best for them and their patients. We don't believe this is something that should be exclusive, or come at an exorbitant cost. This is the freedom and usability that everyone in healthcare should be accustomed to," commented Howard Messing, MEDITECH President & CEO.
- AliveCor is ranked #1 Most Innovative Company in Artificial Intelligence by Fast Company
- Effects of barcodes within healthcare supply chain management
- Sangamo Therapeutics partners with Gilead Sciences in a new $3bn deal
“In 2017, we signed 92 healthcare organisations with 47 of the healthcare organisations representing new customers to the company," commented Executive Vice President, Helen Waters. "We are the only EHR vendor to offer a full-scale EHR designed specifically for the post-meaningful use era."
MEDITECH has cemented its presence in 22 countries, providing increased efficiencies within the healthcare space. With a $480.9mn combined product and service revenue in 2017, its operating costs have also been reduced – an impressive feat.
This year alone has seen the company partner with Arcadia Healthcare Solutions, where it will drive the organisation’s population health management tools through the increased use of data analytics. However, more importantly, MEDITECH has also been ranked ‘Best in KLAS’ through KLAS’ Software & Services report for the fourth year running, highlighting its significance within the electronic healthcare management industry.
Skin Analytics wins NHSX award for AI skin cancer tool
An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system.
NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion.
Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making.
In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog.
Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening.
DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.
Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.
Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges.
"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”